ahlam1399
07-28-2016, 07:25 AM
Exclusive: Advent, CVC bid for inVentiv ahead of IPO: sources
(Reuters) - Buyout firms Advent International and CVC Capital Partners have made offers to acquire inVentiv Group Holdings, a pharmaceutical research firm seeking to go public at a valuation of over $4 billion including debt, people familiar with the matter said.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=bQdQSbckv5s:h86OddNyVCw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=bQdQSbckv5s:h86OddNyVCw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/bQdQSbckv5s
(Reuters) - Buyout firms Advent International and CVC Capital Partners have made offers to acquire inVentiv Group Holdings, a pharmaceutical research firm seeking to go public at a valuation of over $4 billion including debt, people familiar with the matter said.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=bQdQSbckv5s:h86OddNyVCw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=bQdQSbckv5s:h86OddNyVCw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=bQdQSbckv5s:h86OddNyVCw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/bQdQSbckv5s